Commission Implementing Regulation (EU) 2021/2071 of 25 November 2021 subjecting certain vaccines and active substances used for the manufacture of such vaccines to export surveillance

1 The following goods shall be subject to export surveillance for a period of 24 months from the date of entry into force of this Regulation: (a) vaccines against SARS-related coronaviruses (SARS-CoV species) currently falling under CN code 30022010, irrespective of their packaging; (b) active substances, including master and working cell banks used for the manufacture of such vaccines, currently falling under CN codes ex29339980, ex29349990, ex30029090 and ex35040090.

2 For the purposes of this Regulation, ‘export’ means: (a) an export of Union goods under the export procedure within the meaning of Article 269(1) of Regulation (EU) No 952/2013; (b) a re-export of non-Union goods within the meaning of Article 270(1) of that Regulation after such goods have been subject to manufacturing operations including filling and packaging within the customs territory of the Union.

The export or re-export declaration of the goods mentioned in Article 1 shall, during the time referred to therein, include the TARIC additional codes mentioned in the Annex, or any corresponding future codes, and shall indicate the number of doses (in case of multi-dose containers, the number of doses for adults).

The Commission shall make the information on the exports publicly available, due account being taken of the confidentiality of the data.

This Regulation shall enter into force on 1 January 2022.